BIIB News and Press, Biogen Inc. From 05/30/24

Do you, or did you, own shares of Biogen Inc. (NASDAQ:BIIB)? Did you purchase your shares between February 3, 2022 and February 13, 2024, inclusive? Did you lose money in your investment in Biogen Inc.? Do you want to discuss your rights? NEW YORK, NY / ACCESSWIRE / May 30, 2...

2024-05-29 18:15:11 ET Summary Gain Therapeutics, Inc.'s drug candidate GT-02287 has best-in-class potential to slow or stop disease progression in Parkinson's disease. Gain is progressing at an impressive speed through its Phase 1 trial. Drug discovery engine Magellan, which ...

Do you, or did you, own shares of Biogen Inc. (NASDAQ:BIIB)? Did you purchase your shares between February 3, 2022 and February 13, 2024, inclusive? Did you lose money in your investment in Biogen Inc.? Do you want to discuss your rights? NEW YORK, NY / ACCESSWIRE / May 29, 20...

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Biogen Inc. (NASDAQ: BIIB)? Did you purchase your shares between February 3, 2022 and February 13, 2024, inclusive? Did you lose money in your investment in Bioge...

"LEQEMBI" Lecanemab) Approved for the Treatment of Alzheimer's Disease in South Korea TOKYO and CAMBRIDGE, Mass., May 28, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Food and Drug Safety (MFDS) in South Korea has approved humanized an...

2024-05-28 00:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-27 01:45:30 ET Summary Gilead is sitting at one of the lowest valuations in the Big Pharma sector, with a high and sustainable 4.6% dividend yield available for new buyers. The stock has an enviable track record of rising strongly in price when turmoil hits Wall Street and...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Biogen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 26, 2024) - Faruqi & Faruqi, LLP, a leading national sec...

2024-05-26 05:30:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Colorado on behalf of all persons and entities who purchased securities of Biogen, Inc. (“Biogen&...